Search by Drug Name or NDC
NDC 62332-0248-05 Acyclovir 50 mg/g Details
Acyclovir 50 mg/g
Acyclovir is a CUTANEOUS OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is ACYCLOVIR.
MedlinePlus Drug Summary
Acyclovir cream is used to treat cold sores (fever blisters; blisters that are caused by a virus called herpes simplex) on the face or lips. Acyclovir ointment is used to treat first outbreaks of genital herpes (a herpes virus infection that causes sores to form around the genitals and rectum from time to time) and to treat certain types of sores caused by the herpes simplex virus in people with weak immune systems. Acyclovir is in a class of antiviral medications called synthetic nucleoside analogues. It works by stopping the spread of the herpes virus in the body. Acyclovir does not cure cold sores or genital herpes, does not prevent outbreaks of these conditions, and does not stop the spread of these conditions to other people.
Related Packages: 62332-0248-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Acyclovir Topical
Product Information
| NDC | 62332-0248 |
|---|---|
| Product ID | 62332-248_fe6c3f23-06a7-4288-9a5d-ce7c11d3ca86 |
| Associated GPIs | 90350010004205 |
| GCN Sequence Number | 007670 |
| GCN Sequence Number Description | acyclovir OINT. (G) 5 % TOPICAL |
| HIC3 | Q5V |
| HIC3 Description | TOPICAL ANTIVIRALS |
| GCN | 31640 |
| HICL Sequence Number | 004183 |
| HICL Sequence Number Description | ACYCLOVIR |
| Brand/Generic | Generic |
| Proprietary Name | Acyclovir |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acyclovir |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | OINTMENT |
| Route | CUTANEOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/g |
| Substance Name | ACYCLOVIR |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Pharmaceutical Class | DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [ |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209000 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62332-0248-05 (62332024805)
| NDC Package Code | 62332-248-05 |
|---|---|
| Billing NDC | 62332024805 |
| Package | 1 TUBE in 1 CARTON (62332-248-05) / 5 g in 1 TUBE |
| Marketing Start Date | 2019-04-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |